Prabhudas Lilladher recommended accumulate rating on Torrent Pharmaceuticals with a target price of Rs 3670 in its research ...

On the operating front, EBITDA for the quarter was reported at ₹964 Crore. It was 9.20% higher than ₹883 in Q4FY24.

Torrent Pharma's US business is set to benefit from new launches and stronger growth momentum, while Germany is likely to see ...

IndusInd Bank, Oil & Natural Gas Corporation (ONGC), Astral, Colgate Palmolive (India), H.G. Infra Engineering, InterGlobe ...

Indian drugmaker Torrent Pharmaceuticals missed fourth-quarter profit and revenue estimates on Tuesday, hurt by currency depreciation in Brazil, its top overseas market by revenue.

MUMBAI: Torrent Pharma has named Aman Mehta, the older son of chairman Samir Mehta, as MD, solidifying the succession plan at ...

Nifty Pharma stocks, including GSK, Jubilant Pharmova, Eris Life, Gland Pharma and Torrent Pharma, saw gains up to 8% as ...

Net Sales at Rs 2,433.00 crore in March 2025 up 13.53% from Rs. 2,143.00 crore in March 2024. Quarterly Net Profit at Rs. 474.00 crore in March 2025 up 15.61% from Rs. 410.00 crore in March 2024.

Morgan Stanley believes India's fundamentals remain strong, supported by macro stability, improving terms of trade, declining ...

Aman Mehta, third generation of Torrent Group’s founder Mehta family, was on Tuesday appointed Managing Director of the ...

Torrent Pharmaceuticals is entering a new chapter as Aman Mehta, next-gen scion of the Mehta family, prepares to take over as ...

Torrent Pharmaceuticals reports strong revenue growth in key markets, posting a 15.4% rise in net profit for FY 2024-25.